{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-001109","form_type":"8-K","ticker":"PHCI","cik":"0001620749","company_name":"Panamera Holdings Corp","filed_at":"2022-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.516491+00:00","generated_at":"2026-06-25T07:40:06.553811+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Panamera Holdings hires board member Barakat as clinical officer under consulting deal","bullets":["Entered consulting agreement with First DB Ventures LP at $8,333/month for healthcare consulting.","Board member Christopher Barakat appointed Clinical Business Development Officer to serve under the agreement.","Both the consulting and employment arrangements are month-to-month at-will.","Compensation is $8,333 per month for consulting services."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-001109","json":"https://secwatch.observer/filing/0001640334-22-001109.json","markdown":"https://secwatch.observer/filing/0001640334-22-001109.md","text":"https://secwatch.observer/filing/0001640334-22-001109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620749/000164033422001109/0001640334-22-001109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620749/000164033422001109/phci_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:40:06.553811+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9c7ad0de8","claim":"Christopher Barakat was appointed as Clinical Business Development Officer at Panamera Holdings Corp.","evidence_excerpt":"entered into an Employment Contract with Christopher Barakat, a member of our board of directors, to serve in the capacity of a Clinical Business Development Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1620749/000164033422001109/0001640334-22-001109-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Clinical Business Development Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}